JDRF Gala attracts the support of more than 800
HARTFORD, CONN. The North Central Connecticut and Western Massachusetts Chapter of the Juvenile Diabetes Research Foundation (JDRF) hosted its 2011 Promise Ball, Set Sail for the Cure, on May 14 at the Connecticut Convention Center. The event attracted more than 800 guests from across Connecticut and Massachusetts and raised more than $1.24 million for research to find a cure for diabetes and its complications.
JDRF recognized CIGNA with its Star of Hope Award for the company's long-standing commitment to the Foundation's mission. David M. Cordani, president and CEO of CIGNA, was presented with the award by the Ball's 2011 Honorary Chair, Jim Calhoun, head coach of the 2011 NCAA University of Connecticut Men's Basketball Champions. NBC Connecticut's Kevin Nathan served as emcee of the Ball.
"Each and every day, the CIGNA team works to improve the health of our communities. It was my privilege to accept the Star of Hope Award at the JDRF Promise Ball on our team's behalf," Cordani, said. "I was inspired by the personal stories of those individuals and families affected by diabetes. And more importantly, I am proud to have been a part of this event that raised money and awareness for the children and families battling juvenile diabetes."
Eleven-year-old JDRF Youth Ambassador Nina Pennoyer, who was diagnosed with type 1 diabetes at age five, was the evening's featured speaker and received an emotional standing ovation from the audience after sharing what it is like to live with the disease.
Her remarks were followed by JDRF's signature Fund A Cure program, during which 100 percent tax-deductible donations were made to research.
To lend support to JDRF's Fund A Cure program, visit "www.jdrfctma.org"
JDRF is the leader in research leading to a cure for type 1 diabetes in the world and is the largest charitable funder and advocate of diabetes science worldwide. Its mission is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 test their blood sugar and give themselves insulin injections multiple times or use a pump every day. Even with that intensive care, insulin is not a cure, nor does it prevent the disease's eventual complications of kidney failure, blindness, heart disease, stroke, and amputation.
Since 1970, JDRF has awarded more than $1.5 billion to diabetes research, including nearly $107 million in 22 countries in FY2009.